PDA urges pharmacists not to sign fit notes that lie beyond their scope of competence

Date:

Share post:

The Pharmacists’ Defence Association (PDA) has advised completing mandatory training once available to those who wish to sign fit notes.

However, it advises pharmacists not to sign fit notes where the required therapeutic, diagnostic, or examination skills lie outside their scope of competence.

The association said: “The government guidance on fit notes only provides guidance for GPs, employers, hospital doctors, and occupational health practitioners. This excludes pharmacists.”

“The PDA’s understanding is that the healthcare professionals legally able to sign fit notes from 1 July 2022 must complete mandatory training before they start to do so. This e-learning is being developed by Health Education England and will be made available after 1 July 2022.”

The PDA expects further information and guidance to be available from 1 July 2022.

Pharmacists with questions and concerns or under pressure to sign fit notes prematurely are encouraged to contact the PDA at [email protected].

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue June 2023

Related articles

MHRA grants authorisation for LEO Pharma’s Adtralza 2 mL pen solution

The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the marketing authorisation of Adtralza, a dermatological solution...

Grundon launches maiden UK-wide inhaler recycling programme

Grundon Waste Management has introduced what it claims to be the UK's first verified nationwide inhaler return and...

‘Record fine imposed on hydrocortisone manufacturers for dominant position abuse and 10,000% price increase’

The Competition Appeal Tribunal (CAT) has upheld the Competition and Markets Authority’s (CMA) findings against two pharmaceutical manufacturers...

Vision Report: Legal reforms, adequate funding imperative for success of community pharmacy

Achieving the community pharmacy vision necessitates legal adjustments and additional funding beyond recent boosts, the pharmacy vision document...